Fc epsilon RI-expressing antigen-presenting cells: New players in the atopic game

被引：64

作者：

Bieber, T

机构：

[1] Dept. of Dermatology, Ludwig-Maximilians University Munich, Frauenlobstrasse 9

来源：

IMMUNOLOGY TODAY | 1997年 / 18卷 / 07期

关键词：

D O I：

10.1016/S0167-5699(97)01046-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

What is the role of Fc epsilon RI on professional antigen-presenting cells (APCs)? Here, Thomas Bieber speculates how Fc epsilon RI-expressing APCs may trigger primary and secondary immune responses, T-cell skewing ann inflammation.

引用

页码：311 / 313

页数：3

共 17 条

[1] HUMAN EPIDERMAL LANGERHANS CELLS EXPRESS THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN-E (FC-EPSILON-RI) [J].

BIEBER, T ;

DELASALLE, H ;

WOLLENBERG, A ;

HAKIMI, J ;

CHIZZONITE, R ;

RING, J ;

HANAU, D ;

DELASALLE, C .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1285-1290

[2]

BIEBER T, IN PRESS INT ALLERGY

[3] ROLE OF B-CELL RECEPTOR IG-ALPHA AND IG-BETA SUBUNITS IN MHC CLASS II-RESTRICTED ANTIGEN PRESENTATION [J].

BONNEROT, C ;

LANKAR, D ;

HANAU, D ;

SPEHNER, D ;

DAVOUST, J ;

SALAMERO, J ;

FRIDMAN, WH .

IMMUNITY, 1995, 3 (03) :335-347

[4] DEMONSTRATION OF THE HIGH-AFFINITY IGE RECEPTOR ON HUMAN LANGERHANS CELLS IN NORMAL AND DISEASED SKIN [J].

GRABBE, J ;

HAAS, N ;

HAMANN, K ;

KOLDE, G ;

HAKIMI, J ;

CZARNETZKI, BM .

BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :120-123

[5] Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells [J].

Heufler, C ;

Koch, F ;

Stanzl, U ;

Topar, G ;

Wysocka, M ;

Trinchieri, G ;

Enk, A ;

Steinman, RM ;

Romani, N ;

Schuler, G .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (03) :659-668

[6] High-affinity IgE receptor (Fc epsilon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma [J].

Humbert, M ;

Grant, JA ;

TabordaBarata, L ;

Durham, SR ;

Pfister, R ;

Menz, G ;

Barkans, J ;

Ying, S ;

Kay, AB .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) :1931-1937

[7]

JURGENS M, 1995, J IMMUNOL, V155, P5184

[8]

MACATONIA SE, 1995, J IMMUNOL, V154, P5071

[9]

MAURER D, 1995, J IMMUNOL, V154, P6285

[10]

Maurer D, 1996, J IMMUNOL, V157, P607

← 1 2 →